KIT and acute myeloid leukemia: The most inherent characteristics contributing to this unfavorable prognosis include the absence of KIT D816V in approximately 50% of MCL patients and the presence of an aberrant karyotype in 56% or a complex karyotype in 15% of patients with SM-AML.